Related Publications - Farletuzumab (MORAb-003)

Farletuzumab is a humanized IgG1 antibody targeting Folate Receptor Alpha which is over-expressed on a number of epithelial-derived cancers such as ovarian, endometrial, breast, renal, lung, colorectal and brain cancers.

Posters